More articles from Clinical (Radiobiology/Dosimetry/Safety)

Open Access
Evaluation of safety and dosimetry of ¹⁷⁷Lu DOTA-ZOL for therapy of bone metastases
Rene Fernandez, Elisabeth Eppard, Wencke Lehnert, Luis David Jimenez-Franco, Cristian Soza-Ried, Matias Ceballos, Jessica Ribbeck, Andreas Kluge, Frank Roesch, Marian Meckel, Konstantin Zhernosekov, Vasko Kramer and Horacio Amaral

Journal of Nuclear Medicine January 8, 2021, jnumed.120.255851; DOI: https://doi.org/10.2967/jnumed.120.255851
You have access
Feasibility of single-time-point dosimetry for radiopharmaceutical therapies
Xinchi Hou, Julia Brosch, Carlos Uribe, Alessandro Desy, Guido Boning, Jean-Mathieu Beauregard, Anna Celler and Arman Rahmim

Journal of Nuclear Medicine October 30, 2020, jnumed.120.254656; DOI: https://doi.org/10.2967/jnumed.120.254656
You have access
Deep learning generation of synthetic intermediate projections improves ¹⁷⁷Lu SPECT images reconstructed with sparsely acquired projections
Tobias Ryden, Martijn van Essen, Ida Marin, Johanna Svensson and Peter Bernhardt

Journal of Nuclear Medicine August 28, 2020, jnumed.120.245548; DOI: https://doi.org/10.2967/jnumed.120.245548
You have access
Dissimilar DNA Damage to Blood Lymphocytes after ¹⁷⁷Lu-labeled DOTATOC or PSMA Therapy
Philipp Ritt, Camille Jobic, Christian Schmidkonz, Torsten Kuwert, Michael Uder and Michael Brand

Journal of Nuclear Medicine July 31, 2020, jnumed.120.243782; DOI: https://doi.org/10.2967/jnumed.120.243782

Main menu